Delivery Order SPE2DB24D2205-SPE2DB25FECGP
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$99K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KISQALI 400 MG DAILY DOSE 42S medication. The contract has a ceiling value of $8,605.98 and an ultimate completion date of May 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The $25,866.07 fixed-price delivery order is for the provision of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of May 9, 2024. This award is associated with a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,281.68 contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication, to support federal healthcare programs. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565296458 KISQALI 600 MG DAILY DOSE 63S medication. The award, valued at $38,575.52, has a completion date of July 31, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,247,998 units of the drug KISQALI 400 MG DAILY DOSE 42S, with a ceiling value of $33,893.30. The contract has a period of performance through May 15, 2025 and is a firm fixed-price type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,605.98 firm fixed price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. This award is not associated with a set-aside program. The contract has an ultimate completion date of May 7, 2025 and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KISQALI 200 MG DAILY DOSE UU 21S, a pharmaceutical product. The contract has a firm fixed price of $4,315.85 and a completion date of May 20, 2025. This delivery order is not set aside for any particular business type. The contract is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,631.72, is for the supply of KISQALI 200 MG DAILY DOSE medication. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication KISQALI 400 MG DAILY DOSE 42S. The contract has a firm fixed price of $10,415.81 and an ultimate completion date of March 31, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,406.93, is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves...